Anal Squamous Cell Carcinoma clinical trials

Explore recruiting anal squamous cell carcinoma clinical trials.

Recruiting anal squamous cell carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anal Squamous Cell Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed by chemoradiotherapy compared to standard chemoradiotherapy for locally advanced anal squamous cell carcinoma (T3-4 or N1a, b or c)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Netherlands, France, Denmark, Germany, Norway, Italy +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Anal Squamous Cell Carcinoma trials by city

Anal Squamous Cell Carcinoma clinical trials

Recruiting anal squamous cell carcinoma studies right now

Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer.

Agnostic Therapy in Rare Solid Tumors

E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers

Adaptive Radiation in Anal Cancer

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach

Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes

E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers

Tiraglolumab Atezolizumab and Chemoradiotherapy in Localized Anal Carcinoma (TIRANUS)

Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer

Also recruiting in Europe

PRODIGE 85 (FFCD 1804) – KANALRAD Prospective randomized phase III study evaluating induction chemotherapy (modified DCF 4 cycles) followed by chemoradiotherapy compared to standard chemoradiotherapy for locally advanced anal squamous cell carcinoma (T3-4 or N1a, b or c)

A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects with Advanced Solid Tumors (KEYNOTE-158)

Anal Squamous Cell Carcinoma trials by city

Other conditions